These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 4389304

  • 1. [Clinical test on the effect of the new antihistaminic preparation HS-592 (Tavegyl, Sandoz)].
    Zukowski W, Smolik R, Kmietowicz-Zukowska A, Gruszka S, Kwiatkowski S.
    Przegl Lek; 1969 Apr 14; 25(4):379-82. PubMed ID: 4389304
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Evaluation of the clinical usefulness of the antihistamine preparation HS-592 (Tavegyl-Sandoz) in treatment of allergic rhinitis and sinusitis].
    Semczuk B, Klonowski S.
    Pol Tyg Lek; 1970 Feb 23; 25(8):303-5. PubMed ID: 4392044
    [No Abstract] [Full Text] [Related]

  • 4. [Bikarfen--a new Soviet antihistaminic and antiserotonin preparation in the therapy of allergic dermatoses].
    Anton'ev AA, Kaminka ME, Absava GI, Poroshina IuA, Ushakov IV.
    Vestn Dermatol Venerol; 1988 Feb 23; (10):68-72. PubMed ID: 2906194
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Ambulatory testing of a new antihistaminic. Experience with Tavegil].
    Weitgasser H.
    Munch Med Wochenschr; 1967 May 19; 109(20):1134-6. PubMed ID: 4384702
    [No Abstract] [Full Text] [Related]

  • 10. [Therapeutic evaluation of a new antihistaminic: HS-592].
    Guimarães NA, Fonseca O.
    Hospital (Rio J); 1968 Nov 19; 74(5):1511-4. PubMed ID: 4388711
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Experimental and clinical studies of a new histamine antagonist].
    Kallós P.
    Lakartidningen; 1969 Jun 16; 66():Suppl II:57+. PubMed ID: 4392857
    [No Abstract] [Full Text] [Related]

  • 15. [Clinical and experimental studies with the antihistaminic Tavegyl in dermatologic patients].
    Grabner K.
    Wien Klin Wochenschr; 1970 Sep 04; 82(36):625-7. PubMed ID: 4396798
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A new antihistamine hc20-511 compared with dimetinden (fenistil retard) in the treatment of chronic urticaria and other pruritic dermatoses.
    Kuokkanen K.
    Acta Allergol; 1975 Jul 04; 30(2-3):73-9. PubMed ID: 239517
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A clinical trial of brompheniramine maleate in chronic urticaria.
    Warin RP, Moore-Robinson M.
    Practitioner; 1966 Aug 04; 197(178):212-4. PubMed ID: 4380315
    [No Abstract] [Full Text] [Related]

  • 20. [Experience with a new antihistaminic (Tavegyl, Sandoz) in a dermatologic-allergologic practice].
    Wortmann F.
    Dermatol Wochenschr; 1968 Nov 30; 154(48):1129-33. PubMed ID: 4389418
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.